Global Live Cell Imaging Market 2022
- Market Report
- ID: HI25247G
- Delivery Time: 1 Business Day
- Tag: Live Cell Imaging
Description
The global live cell imaging market is poised to grow by US$ 941.4 million from 2022 to 2028, registering a CAGR of 6.9% during the forecast period, according to StrategyHelix.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for live cell imaging. The global live cell imaging market is segmented on the basis of component, application, and region. By component, the global live cell imaging market has been segmented into equipment, consumables, software and services. The equipment segment was the largest contributor to the global live cell imaging market in 2021. Based upon application, the global live cell imaging market is categorized into cell biology, developmental biology, stem cell biology, drug discovery, others. According to the research, the cell biology segment had the largest share in the global live cell imaging market. In terms of geography, the global live cell imaging market has been segmented into North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2021.
The global live cell imaging market is highly competitive. The key players in the live cell imaging market include Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc. Competitive landscape gives a description of the competitive nature of the global live cell imaging market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the live cell imaging market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Component: equipment, consumables, software and services
Application: cell biology, developmental biology, stem cell biology, drug discovery, others
Region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc.
Key Benefits for Stakeholders
– Get a comprehensive picture of the global live cell imaging market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Live cell imaging market overview
Part 3. Market breakdown by component
– Equipment
– Consumables
– Software and services
Part 4. Market breakdown by application
– Cell biology
– Developmental biology
– Stem cell biology
– Drug discovery
– Others
Part 5. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America
Part 6. Key companies
– Becton Dickinson and Company
– Carl Zeiss AG
– Danaher Corporation
– Merck KGaA
– Nikon Instruments Inc.
– Olympus Corporation
– PerkinElmer Inc.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer
USD 450